ACCOY -001 - Moderate to Severe Pain - Pivotal Trial (Phase IIIa) 

ACCOY -002 - Moderate to Severe Pain

ACCOY -003 - Moderate to Severe Pain 

ACCOY -004 - Moderate to Severe Pain  

* This is not a complete list of ACCOY's pipeline products.

PRODUCT PIPELINE

NOVEL PAIN THERAPIES

OTHER NOVEL THERAPIES OF INTEREST

Cardiovascular

CNS

GI

Metabolic

Narrow Therapeutic Window Drugs

ACCOY is focused on the development of "Novel New Therapies" that address significant medical needs, prevent dose-mediated adverse events, enable point of care medication and patient management and save money on the total cost of care.  ACCOY has identified over 100 drugs, with significant unmet medical needs, for development that historically have been subject to abuse, misuse, addiction, dependence, tolerance, diversion, underdosing, overdosing, under prescribing, over prescribing, have narrow therapeutic windows, or that failed in clinical trials due to safety concerns.

"The products are exciting and potentially game changing for the pain community. "

                                                                                                                                                                                                                                                               Lynn Webster, MD

NOVEL CARDIOVASCULAR THERAPIES

ACCOY -006 - Atrial Fibrillation

ACCOY -007 - Antihypertensive

NOVEL IRRITABLE BOWEL SYNDROME THERAPIES

ACCOY -005 - Diarhea Predominant Irritable Bowel Syndrome